Touloupou P, Fronterre C, Cano J, Prada J, Smith M, Kontoroupis P
    
    
    Clin Infect Dis. 2024; 78(Suppl 2):S108-S116.
  
  
    PMID: 38662704
    
          PMC: 11045016.
    
          DOI: 10.1093/cid/ciae071.
      
 
                                  
  
    Miri E, Eigege A, Kahansim B, Nwodu K, Sambo Y, Mancha B
    
    
    Am J Trop Med Hyg. 2022; 108(1):37-40.
  
  
    PMID: 36450227
    
          PMC: 9833078.
    
          DOI: 10.4269/ajtmh.22-0491.
      
 
                                  
  
    Eneanya O, Gankpala L, Goss C, Momolu A, Nyan E, Gray E
    
    
    Acta Trop. 2022; 231:106437.
  
  
    PMID: 35405102
    
          PMC: 9168441.
    
          DOI: 10.1016/j.actatropica.2022.106437.
      
 
                                  
  
    Bush S, Richards F, Zhang Y
    
    
    Int Health. 2020; 13(Suppl 1):S44-S47.
  
  
    PMID: 33349880
    
          PMC: 7753161.
    
          DOI: 10.1093/inthealth/ihaa049.
      
 
                                  
  
    Smith M, Griswold E, Singh B, Miri E, Eigege A, Adelamo S
    
    
    PLoS Comput Biol. 2020; 16(7):e1007506.
  
  
    PMID: 32692741
    
          PMC: 7394457.
    
          DOI: 10.1371/journal.pcbi.1007506.
      
 
                              
              
                              
                                      
  Risk factors associated with failing pre-transmission assessment surveys (pre-TAS) in lymphatic filariasis elimination programs: Results of a multi-country analysis.
  
    Burgert-Brucker C, Zoerhoff K, Headland M, Shoemaker E, Stelmach R, Karim M
    
    
    PLoS Negl Trop Dis. 2020; 14(6):e0008301.
  
  
    PMID: 32479495
    
          PMC: 7289444.
    
          DOI: 10.1371/journal.pntd.0008301.
      
 
                                          
                                                          
  Post-Treatment Surveillance for Lymphatic Filariasis in Plateau and Nasarawa States, Nigeria: Results of Transmission Assessment Surveys.
  
    Eigege A, Noland G, Adelamo S, Nwodu K, Sallau A, Umaru J
    
    
    Am J Trop Med Hyg. 2020; 102(6):1404-1410.
  
  
    PMID: 32228796
    
          PMC: 7253131.
    
          DOI: 10.4269/ajtmh.20-0020.
      
 
                                          
                                                          
  The Interruption of Transmission of Human Onchocerciasis by an Annual Mass Drug Administration Program in Plateau and Nasarawa States, Nigeria.
  
    Richards F, Eigege A, Umaru J, Kahansim B, Adelamo S, Kadimbo J
    
    
    Am J Trop Med Hyg. 2020; 102(3):582-592.
  
  
    PMID: 32043442
    
          PMC: 7056427.
    
          DOI: 10.4269/ajtmh.19-0577.
      
 
                                          
                                                          
  The social, physical and economic impact of lymphedema and hydrocele: a matched cross-sectional study in rural Nigeria.
  
    Eneanya O, Garske T, Donnelly C
    
    
    BMC Infect Dis. 2019; 19(1):332.
  
  
    PMID: 31014256
    
          PMC: 6480436.
    
          DOI: 10.1186/s12879-019-3959-6.
      
 
                                          
                                                          
  Elimination of lymphatic filariasis in South East Asia.
  
    Specht S, Suma T, Pedrique B, Hoerauf A
    
    
    BMJ. 2019; 364:k5198.
  
  
    PMID: 30670373
    
          PMC: 6340355.
    
          DOI: 10.1136/bmj.k5198.
      
 
                                          
                                                          
  Integrated risk mapping and landscape characterisation of lymphatic filariasis and loiasis in South West Nigeria.
  
    Brant T, Okorie P, Ogunmola O, Ojeyode N, Fatunade S, Davies E
    
    
    Parasite Epidemiol Control. 2018; 3(1):21-35.
  
  
    PMID: 29774296
    
          PMC: 5952684.
    
          DOI: 10.1016/j.parepi.2017.12.001.
      
 
                                          
                                                          
  Criteria to Stop Mass Drug Administration for Lymphatic Filariasis Have Been Achieved Throughout Plateau and Nasarawa States, Nigeria.
  
    Eigege A, Evans D, Noland G, Davies E, Umaru J, Adelamo S
    
    
    Am J Trop Med Hyg. 2017; 97(3):677-680.
  
  
    PMID: 28749759
    
          PMC: 5590580.
    
          DOI: 10.4269/ajtmh.16-0843.
      
 
                                          
                                                          
  Application of a household-based molecular xenomonitoring strategy to evaluate the lymphatic filariasis elimination program in Tamil Nadu, India.
  
    Subramanian S, Jambulingam P, Chu B, Sadanandane C, Vasuki V, Srividya A
    
    
    PLoS Negl Trop Dis. 2017; 11(4):e0005519.
  
  
    PMID: 28406927
    
          PMC: 5404881.
    
          DOI: 10.1371/journal.pntd.0005519.
      
 
                                          
                                                          
  Can community-based integrated vector control hasten the process of LF elimination?.
  
    Sunish I, Kalimuthu M, Kumar V, Munirathinam A, Nagaraj J, Tyagi B
    
    
    Parasitol Res. 2016; 115(6):2353-62.
  
  
    PMID: 26969179
    
    
          DOI: 10.1007/s00436-016-4985-6.
      
 
                                          
                                                          
  Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west Ethiopia.
  
    Endeshaw T, Taye A, Tadesse Z, Katabarwa M, Shafi O, Seid T
    
    
    Pathog Glob Health. 2016; 109(7):344-51.
  
  
    PMID: 26878935
    
          PMC: 4768627.
    
          DOI: 10.1080/20477724.2015.1103501.
      
 
                                          
                                                          
  Integrating vector control across diseases.
  
    Golding N, Wilson A, Moyes C, Cano J, Pigott D, Velayudhan R
    
    
    BMC Med. 2015; 13:249.
  
  
    PMID: 26423147
    
          PMC: 4590270.
    
          DOI: 10.1186/s12916-015-0491-4.
      
 
                                          
                                                          
  A critical assessment of vector control for dengue prevention.
  
    Achee N, Gould F, Perkins T, Reiner Jr R, Morrison A, Ritchie S
    
    
    PLoS Negl Trop Dis. 2015; 9(5):e0003655.
  
  
    PMID: 25951103
    
          PMC: 4423954.
    
          DOI: 10.1371/journal.pntd.0003655.
      
 
                                          
                                                          
  Cessation of mass drug administration for lymphatic filariasis in Zanzibar in 2006: was transmission interrupted?.
  
    Rebollo M, Mohammed K, Thomas B, Ame S, Mohammed Ali S, Cano J
    
    
    PLoS Negl Trop Dis. 2015; 9(3):e0003669.
  
  
    PMID: 25816287
    
          PMC: 4376862.
    
          DOI: 10.1371/journal.pntd.0003669.
      
 
                                          
                                                          
  Elimination of lymphatic filariasis in the Gambia.
  
    Rebollo M, Sambou S, Thomas B, Biritwum N, Jaye M, Kelly-Hope L
    
    
    PLoS Negl Trop Dis. 2015; 9(3):e0003642.
  
  
    PMID: 25785587
    
          PMC: 4364952.
    
          DOI: 10.1371/journal.pntd.0003642.
      
 
                                          
                                                          
  A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration.
  
    Rao R, Nagodavithana K, Samarasekera S, Wijegunawardana A, Premakumara W, Perera S
    
    
    PLoS Negl Trop Dis. 2014; 8(11):e3281.
  
  
    PMID: 25393404
    
          PMC: 4230885.
    
          DOI: 10.1371/journal.pntd.0003281.